Nanoligent Alternatives & Competitors
12 companies similar to Nanoligent — Our mision is to improve the life of patients by designing new drugs that select...
Companies similar to Nanoligent
Orna Therapeutics
Wholly Owned Subsidiary of Eli Lilly and Company
Watertown, United States
Cytimmune Sciences
Developing safer more effective therapies that can attack tumors on multiple fronts simult...
Rockville, United States
Lyon, France
EraCal Therapeutics
Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-viv...
Basel, Switzerland
Track all Nanoligent competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
Spain
Novelogics Biotechnology Inc.
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...
Canada
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
San Diego, United States
ESPERANCE PHARMACEUTICALS, INC.
Pioneering a new era of anticancer treatment with drugs that precisely target and eliminat...
RS Research
Clinically-validated biotech company for targeted therapies, disrupting the efficacy-toxic...
Istanbul, Turkey
Bound Therapeutics
Safe and effective next generation RNA therapeutics
Cherry Hill, United State...
Evox Therapeutics Ltd
Changing the course of CNS disease
Oxford, United Kingdom
Noble Life Sciences Inc
Preclinical CRO-in vitro and in vivo testing services for cell and gene therapy, biologics...
United States
About Nanoligent
Nanoligent is a Spanish biotechnology and pharmaceutical startup founded in 2017, with a mission to improve the lives of patients by developing new drugs that selectively target cells affected by disease. Their innovative approach utilizes state-of-the-art protein engineering and nanobiotechnology to design more effect...
Biotech, Drug Design, Nanobiotechnology, Cancer Treatment, Metastasis, Protein Engineering, Nanoparticle, Targeted Therapy, Preclinical Development, Drug Delivery, Therapeutic Biologics, CXCR4 Receptors, Patient-focused, In Vivo Testing, University Spin-off
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Nanoligent and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Nanoligent on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
